A first in disease phase 2, randomised, controlled trial of Granulocyte-Macrophage Colony-Stimulating factor neutralisation for Axial Spondyloarthritis (NAMASTE study)

Claudia Worth*, Hussein Al-Mossawi, Joanne MacDonald, Benjamin Fisher, Antoni Chan, Raj Sengupta, Jon Packham, Karl Gaffney, Nicola Gullick, Jonathan Cook, Tim Corn, James Teh, Pedro Machado, Peter Taylor, Paul Bowness

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

73 Downloads (Pure)

Abstract


Original languageEnglish
JournalThe Lancet Rheumatology
Publication statusAccepted/In press - 15 Apr 2024

Bibliographical note

Not yet published as of 16/04/2024.

Cite this